Logo
x

Search

Subscribe Now

chronic inflammatory demyelinating polyneuropathy

Pfizer's Panzyga Receives the US FDA's Approval of sBLA for Chronic Inflammatory Demyelinating Polyneuropathy

Pfizer's Panzyga Receives the US FDA's Approval of sBLA for Chronic Inflammatory Demyelinating Polyneuropathy

  • February 15, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.